Open Access
BIO Web Conf.
Volume 60, 2023
2022 4th International Conference on Biotechnology and Food Science (BFS 2022)
Article Number 01001
Number of page(s) 6
Section Biochemical Application and Genetic Engineering
Published online 11 May 2023
  • Angelucci, F., et al., MicroRNAs in Alzheimer’s disease: diagnostic markers or therapeutic agents? Frontiers in pharmacology, 2019(10): 665. [CrossRef] [PubMed] [Google Scholar]
  • Chen, Y.-G., Research progress in the pathogenesis of Alzheimer’s disease. Chinese medical journal, 2018. 131(13): 1618. [CrossRef] [PubMed] [Google Scholar]
  • Dubois, B., et al., Clinical diagnosis of Alzheimer’s disease: recommendations of the International Working Group. The Lancet Neurology, 2021. [PubMed] [Google Scholar]
  • Femminella, G.D., N. Ferrara, and G. Rengo, The emerging role of microRNAs in Alzheimer’s disease. Frontiers in physiology, 2015(6): 40. [PubMed] [Google Scholar]
  • Folch, J., et al., Current research therapeutic strategies for Alzheimer’s disease treatment. Neural plasticity, 2016. [PubMed] [Google Scholar]
  • Geng, L., et al., Inhibition of miR-128 abates Aβmediated cytotoxicity by targeting PPAR-γ via NFκB inactivation in primary mouse cortical neurons and Neuro2a cells. Yonsei medical journal, 2018, 59(9): 1096-1106. [CrossRef] [PubMed] [Google Scholar]
  • Hampel, H., et al., Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nature Reviews Neurology, 2018, 14(11): 639-652. [CrossRef] [PubMed] [Google Scholar]
  • Hébert, S.S., N. Sergeant, and L. Buée, MicroRNAs and the regulation of tau metabolism. International journal of Alzheimer’s disease, 2012. [Google Scholar]
  • Jiang, Y., et al., Micro-RNA-137 inhibits tau hyperphosphorylation in Alzheimer’s disease and targets the CACNA1C gene in transgenic mice and human neuroblastoma SH-SY5Y cells. Medical science monitor: international medical journal of experimental and clinical research, 2018, 24: 5635. [Google Scholar]
  • Kehl, T., et al., About miRNAs, miRNA seeds, target genes, and target pathways. Oncotarget, 2017. 8(63): 107167. [CrossRef] [PubMed] [Google Scholar]
  • Kehl, T., et al., About miRNAs, miRNA seeds, target genes and target pathways. Oncotarget, 2017. 8(63): 107167. [CrossRef] [PubMed] [Google Scholar]
  • Li, J., et al., miR‐219‐5p inhibits tau phosphorylation by targeting TTBK1 and GSK‐3β in Alzheimer’s disease. Journal of cellular biochemistry, 2019, 120(6): 9936-9946. [CrossRef] [PubMed] [Google Scholar]
  • Liu, W., J. Zhao, and G. Lu, miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer’s disease. Biochemical and biophysical research communications, 2016, 478(2): 852-857. [CrossRef] [PubMed] [Google Scholar]
  • McKhann, G.M., et al., The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging‐Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & dementia, 2011, 7(3): 263-269. [CrossRef] [PubMed] [Google Scholar]
  • Miya Shaik, M., et al., The role of microRNAs in Alzheimer’s disease and their therapeutic potentials. Genes, 2018, 9(4): 174. [CrossRef] [PubMed] [Google Scholar]
  • Santa-Maria, I., et al., Dysregulation of microRNA-219 promotes neurodegeneration through posttranscriptional regulation of tau. The Journal of clinical investigation, 2015, 125(2): 681-686. [CrossRef] [PubMed] [Google Scholar]
  • Schwarz, A.J., The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders. Neurotherapeutics, 2021: 1-23. [PubMed] [Google Scholar]
  • Silvestro, S., P. Bramanti, and E. Mazzon, Role of miRNAs in Alzheimer’s disease and possible fields of application. International journal of molecular sciences, 2019, 20(16): 3979. [CrossRef] [PubMed] [Google Scholar]
  • Smith, P.Y., et al., miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Human molecular genetics, 2015, 24(23): 6721-6735. [CrossRef] [PubMed] [Google Scholar]
  • Walayat, A., Yang, M., and Xiao, D. Therapeutic implication of miRNA in human disease, Antisense therapy. 2018, IntechOpen. [Google Scholar]
  • Wei, W., et al., MicroRNAs in Alzheimer’s disease: Function and potential applications as diagnostic biomarkers. Frontiers in Molecular Neuroscience, 2020, 13: 160. [CrossRef] [PubMed] [Google Scholar]
  • Zhang, J., et al., RETRACTED ARTICLE: MicroRNA-322 cluster promotes tau phosphorylation via targeting brain-derived neurotrophic factor. Neurochemical research, 2018, 43(3): 736-744. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.